Inicio › Cáncer de próstata › Florida › Miami
Ensayos clínicos de Cáncer de próstata en Miami, FL
30 estudios para Cáncer de próstata buscan participantes en centros de Miami y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Reclutando
- University of Miami, Miami
WATER IV PCa (AS Sub-study)
Reclutando
- University of Miami, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- University of Miami, Miami
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
ReclutandoFase 4
- Desai Sethi Urology Institute, Miami
- Sylvester Comprehensive Cancer Center, Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- Biogenix Molecular, LLC, Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
ReclutandoFase 1
- Biogenix Molecular, LLC, Miami
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
Reclutando
- University of Miami Hospitals and Clinics, Miami
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
ReclutandoFase 1
- Sylvester Comprehensive Cancer Center, Miami
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
ReclutandoFase 3
- Research Site, Miami
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
ReclutandoFase 1
- Research Site, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
ReclutandoFase 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
ReclutandoFase 3
- Research Site, Miami
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutandoFase 3
- Baptist Health South, Miami
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
ReclutandoFase 1/2
- Research Site, Miami
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutandoFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
ReclutandoSe aceptan voluntarios sanos
- University of Miami, Miami
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ReclutandoFase 2/3
- Baptist Health South, Miami
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
ReclutandoFase 3
- Biogenix Molecular, LLC, Miami
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
ReclutandoFase 1/2
- Mount Sinai Medical Center, Miami
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ReclutandoFase 2
- Biogenix Molecular, LLC, Miami
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
ReclutandoFase 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
ReclutandoFase 2
- University of Miami, Miami
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
ReclutandoFase 1/2
- Biogenix Molecular LLC, Miami
- NovaCure Health, Miami
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
Reclutando
- University of Miami, Miami
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
ReclutandoEstudio observacional
- University of Miami, Miami
The University of Miami Adapt (UAdapt) Trial
ReclutandoFase 2
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
ReclutandoFase 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Miami
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY101 estudios
- Houston, TX73 estudios
- Los Angeles, CA64 estudios
- Boston, MA56 estudios
- Seattle, WA45 estudios
- St. Louis, MO45 estudios
- Chicago, IL45 estudios
- Baltimore, MD45 estudios
- San Francisco, CA44 estudios
- Philadelphia, PA41 estudios
- Nashville, TN40 estudios
- Washington, DC39 estudios
Otros estudios en Miami
- Cáncer de seno42 estudios
- Cáncer (todos los tipos)36 estudios
- Cáncer de pulmón de células no pequeñas35 estudios
- Obesidad28 estudios
- Cáncer de ovario24 estudios
- Leucemia mielógena aguda24 estudios
- Sobrepeso23 estudios
- Cáncer metastásico22 estudios
- Mieloma múltiple22 estudios
- Cáncer de pulmón22 estudios
- Enfermedad de Alzheimer21 estudios
- Enfermedad de obstrucción pulmonar crónica20 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.